Author:
Zhang Chan,Jiang Xiaochun,Chen Wanlu,Li Qi,Yun Fubin,Yang Xin,Dai Run,Cheng Yujing
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference33 articles.
1. Gene-gene-environment interactions between drugs, transporters, receptors, and metabolizing enzymes: statins, SLCO1B1, and CYP3A4 as an example;Sadee;J Pharm Sci,2013
2. CYP2C9∗3 (1075A>C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics;Zhou;Pharmazie,2013
3. Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin;Zuccaro;Pharmacol Res,2007
4. Genetic polymorphisms in very important pharmacogenomic variants in the Zhuang ethnic group of Southwestern China: a cohort study in the Zhuang population;Li;Medicine,2018
5. Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China;Yan;Gene,2018
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献